Evidence map›Paper›PMID 28975544›Full record

ArticleJournal of cell communication and signaling2018

The role of α9β1 integrin and its ligands in the development of autoimmune diseases.

Shigeyuki Kon, Toshimitsu Uede

Open access · bronzeAbstract read
In one paragraph

Article in Journal of cell communication and signaling, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Assessment of αClinical and experimental medicine · 2023
    Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Localization of integrin heterodimer αAnimal cells and systems · 2020
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Shigeyuki KonDepartment of Molecular Immunology, Faculty of Pharmaceutical Sciences, Fukuyama University, 985-1 Azasanzo, Higashimura-machi, Fukuyama, Hiroshima, 729-0292, Japan. kon@fukuyama-u.ac.jp.ORCID http://orcid.org/0000-0001-5410-8429
Toshimitsu UedeDivision of Molecular Neuro-Immunology, Institute for Genetic Medicine, Hokkaido University, Sapporo, 060-0815, Japan.
Fukuyama University · JPHokkaido University · JP

Funding

KAKENHI JP16K08221KAKENHI JP24590072
6 · The paper itself

Abstract

Adhesion of cells to extracellular matrix proteins through integrins expressed on the cell surface is important for cell adhesion/motility, survival, and differentiation. Recently, α9β1 integrin was reported to be important for the development of autoimmune diseases including rheumatoid arthritis, multiple sclerosis, and their murine models. In addition, ligands for α9β1 integrin, such as osteopontin and tenascin-C, are well established as key regulators of autoimmune diseases. Therefore, this review focused on the role of interactions between α9β1 integrin and its ligands in the development of autoimmune diseases.

Indexed as

Autoimmune diseasesMultiple sclerosisOsteopontinRheumatoid arthritisTenascin-Cα9 integrin

Identifiers

PMID28975544
PMCPMC5842177
OpenAlexW2763949247

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.